Sahmoud Tarek 4
4 · Context Therapeutics Inc. · Filed Aug 12, 2022
Insider Transaction Report
Form 4
Sahmoud Tarek
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-12+25,000→ 25,000 totalExercise: $1.96Exp: 2032-08-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer.